Literature DB >> 28099426

Fetal origins of adult cardiac disease: a novel approach to prevent fetal growth restriction induced cardiac dysfunction using insulin like growth factor.

Tarek Alsaied1, Khaled Omar2, Jeanne F James1, Robert B Hinton1, Timothy M Crombleholme2, Mounira Habli3,4.   

Abstract

BACKGROUND: Fetal growth restriction (FGR) is a risk factor for adult cardiovascular disease. Intraplacental gene transfer of human insulin-like growth factor-1 (IGF-1) corrects birth weight in our mouse model of FGR. This study addresses long term effects of FGR on cardiac function and the potential preventive effect of IGF-1. STUDY
DESIGN: Laparotomy was performed on pregnant C57BL/6J mice at embryonic day 18 and pups were divided into three groups: Sham operated; FGR (induced by mesenteric uterine artery ligation); treatment (intraplacental injection of IGF-1 after uterine artery ligation). Pups were followed until 32 wk of life. Transthoracic echocardiography was performed starting at 12 wk.
RESULTS: Systolic cardiac function was significantly impaired in the FGR group with reduced fractional shortening compared with sham and treatment group starting at week 12 of life (20 ± 4 vs. 31 ± 5 vs. 32 ± 5, respectively, n = 12 for each group; P < 0.001) with no difference between the sham and treatment groups.
CONCLUSION: Intraplacental gene transfer of IGF-1 prevents FGR induced cardiac dysfunction. This suggests that in utero therapy may positively impact cardiac remodeling and prevent adult cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28099426     DOI: 10.1038/pr.2017.18

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  43 in total

1.  Long-term effects of intrauterine growth restriction on cardiac metabolism and susceptibility to ischaemia/reperfusion.

Authors:  Christian F Rueda-Clausen; Jude S Morton; Gary D Lopaschuk; Sandra T Davidge
Journal:  Cardiovasc Res       Date:  2010-11-19       Impact factor: 10.787

2.  Cardiac function and arterial biophysical properties in small for gestational age infants: postnatal manifestations of fetal programming.

Authors:  Arvind Sehgal; Tejas Doctor; Samuel Menahem
Journal:  J Pediatr       Date:  2013-07-26       Impact factor: 4.406

3.  Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart.

Authors:  Georgina M Ellison; Daniele Torella; Santo Dellegrottaglie; Claudia Perez-Martinez; Armando Perez de Prado; Carla Vicinanza; Saranya Purushothaman; Valentina Galuppo; Claudio Iaconetti; Cheryl D Waring; Andrew Smith; Michele Torella; Carlos Cuellas Ramon; Jose Manuel Gonzalo-Orden; Valter Agosti; Ciro Indolfi; Manuel Galiñanes; Felipe Fernandez-Vazquez; Bernardo Nadal-Ginard
Journal:  J Am Coll Cardiol       Date:  2011-06-30       Impact factor: 24.094

4.  Recapitulation of characteristics of human placental vascular insufficiency in a novel mouse model.

Authors:  M Habli; H Jones; B Aronow; K Omar; T M Crombleholme
Journal:  Placenta       Date:  2013-09-27       Impact factor: 3.481

5.  Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.

Authors:  D J Barker; C Osmond; J Golding; D Kuh; M E Wadsworth
Journal:  BMJ       Date:  1989-03-04

6.  Early growth and coronary heart disease and type 2 diabetes: findings from the Helsinki Birth Cohort Study (HBCS).

Authors:  Johan G Eriksson
Journal:  Am J Clin Nutr       Date:  2011-05-25       Impact factor: 7.045

7.  Impaired myocardial performance in a normotensive rat model of intrauterine growth restriction.

Authors:  Carlos Menendez-Castro; Okan Toka; Fabian Fahlbusch; Nada Cordasic; Rainer Wachtveitl; Karl F Hilgers; Wolfgang Rascher; Andrea Hartner
Journal:  Pediatr Res       Date:  2014-03-06       Impact factor: 3.756

8.  Fetal growth restriction results in remodeled and less efficient hearts in children.

Authors:  Fàtima Crispi; Bart Bijnens; Francesc Figueras; Joaquim Bartrons; Elisenda Eixarch; Ferdinand Le Noble; Asif Ahmed; Eduard Gratacós
Journal:  Circulation       Date:  2010-05-24       Impact factor: 29.690

9.  Early programming of weight gain in mice prevents the induction of obesity by a highly palatable diet.

Authors:  Susan E Ozanne; Rohan Lewis; Bridget J Jennings; C Nicholas Hales
Journal:  Clin Sci (Lond)       Date:  2004-02       Impact factor: 6.124

10.  Fetal and amniotic insulin-like growth factor-I supplements improve growth rate in intrauterine growth restriction fetal sheep.

Authors:  Simona C Eremia; Hendrina A de Boo; Frank H Bloomfield; Mark H Oliver; Jane E Harding
Journal:  Endocrinology       Date:  2007-03-08       Impact factor: 4.736

View more
  4 in total

1.  MIR146A and ADIPOQ genetic variants are associated with birth weight in relation to gestational age: a cohort study.

Authors:  Lívia Reis Silva; Anderson Sanches Melo; Cristiana Libardi Miranda Furtado; Rui Alberto Ferriani; Karina Bezerra Salomão; Suleimy Cristina Mazin; Luiz Gonzaga Tone; Viviane Cunha Cardoso; Rosana Maria Dos Reis
Journal:  J Assist Reprod Genet       Date:  2022-06-11       Impact factor: 3.357

Review 2.  Novel Technologies for Target Delivery of Therapeutics to the Placenta during Pregnancy: A Review.

Authors:  Gerald J Pepe; Eugene D Albrecht
Journal:  Genes (Basel)       Date:  2021-08-17       Impact factor: 4.096

Review 3.  Spatiotemporal switching signals for cancer stem cell activation in pediatric origins of adulthood cancer: Towards a watch-and-wait lifetime strategy for cancer treatment.

Authors:  Shengwen Calvin Li; Mustafa H Kabeer
Journal:  World J Stem Cells       Date:  2018-02-26       Impact factor: 5.326

4.  Prenatal Mechanistic Target of Rapamycin Complex 1 (m TORC1) Inhibition by Rapamycin Treatment of Pregnant Mice Causes Intrauterine Growth Restriction and Alters Postnatal Cardiac Growth, Morphology, and Function.

Authors:  Maria Hennig; Saskia Fiedler; Christian Jux; Ludwig Thierfelder; Jörg-Detlef Drenckhahn
Journal:  J Am Heart Assoc       Date:  2017-08-04       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.